Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
New England Journal of MedicinePublished 20 January 2000Open access
Salim Yusuf
Citations8,611
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure in a two-by-two factorial study evaluating ramipril and vitamin E.
Abstract
Ramipril significantly reduces the rates of death, myocardial infarction, and stroke in a broad range of high-risk patients who are not known to have a low ejection fraction or heart failure.
Keywords
Medicine
New England Journal of MedicineEffect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
5,925 Citations1992Marc A. Pfeffer, Eugene Braunwald +16 more
In patients with asymptomatic left ventricular dysfunction after myocardial infarction, long-term administration of captopril was associated with an improvement in survival and reduced morbidity and mortality due to major cardiovascular events.
The LancetEffects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
5,765 Citations1998Lennart Hansson, Alberto Zanchetti +8 more
Intensive lowering of blood pressure in patients with hypertension was associated with a low rate of cardiovascular events and the potential benefit of a low dose of acetylsalicylic acid in the treatment of hypertension was assessed.
New England Journal of MedicineThe Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy
5,377 Citations1993Edmund J. Lewis, Lawrence G. Hunsicker +2 more
Captopril protects against deterioration in renal function in insulin-dependent diabetic nephropathy and is significantly more effective than blood-pressure control alone.
The LancetBlood pressure, stroke, and coronary heart disease
4,511 Citations1990Rory Collins, Richard Peto +12 more
A sufficiently high risk of stroke (perhaps because of age, blood pressure, or, in particular, history of cerebrovascular disease) may be the clearest indication for antihypertensive treatment.
New England Journal of MedicineEffect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions
3,730 Citations1992Salim Yusuf
The angiotensin-converting--enzyme inhibitor enalapril significantly reduced the incidence of heart failure and the rate of related hospitalizations, as compared with the rates in the group given placebo, among patients with asymptomatic left ventricular dysfunction.
Progress in Cardiovascular DiseasesBeta blockade during and after myocardial infarction: An overview of the randomized trials
3,239 Citations1985Salim Yusuf, Richard Peto +3 more
The aim has been not only to review the 65-odd randomized beta blocker trials but also to demonstrate that when many randomized trials have all applied one general approach to treatment, it is often not appropriate to base inference on individual trial results.
BMJCollaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
3,125 Citations1994Antiplatelet Trialists' Collaboration
There was no appreciable evidence that either a higher aspirin dose or any other antiplatelet regimen was more effective than medium dose aspirin in preventing vascular events, so in each of the four main high risk categories overall mortality was significantly reduced.
The LancetEffect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial
2,009 Citations1999Lennart Hansson, Lars Lindholm +11 more
Captopril and conventional treatment did not differ in efficacy in preventing cardiovascular morbidity and mortality and the difference in stroke risk was probably due to the lower levels of blood pressure obtained initially in previously treated patients randomised to conventional therapy.
New England Journal of MedicineVitamin E Supplementation and Cardiovascular Events in High-Risk Patients
1,956 Citations2000The Heart Outcomes Prevention Evaluation Study Investigators
In patients at high risk for cardiovascular events, treatment with vitamin E for a mean of 4.5 years had no apparent effect on cardiovascular outcomes and there were no significant differences in the incidence of secondary cardiovascular outcomes or in death from any cause.
New England Journal of MedicineA Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1,776 Citations1995Lars Køber, Christian Torp‐Pedersen +11 more
Long-term treatment with trandolapril in patients with reduced left ventricular function soon after myocardial infarction significantly reduced the risk of overall mortality, mortality from cardiovascular causes, sudden death, and the development of severe heart failure.
JAMAOverview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials
1,538 Citations1995R. Garg
Reductions for total mortality and the combined endpoint were similar for various subgroups examined, but patients with the lowest ejection fraction appeared to have the greatest benefit.
The LancetRenoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
897 Citations1999Piero Ruggenenti, Annalisa Perna +7 more
In non-diabetic nephropathies, ACE inhibition confers renoprotection even to patients with non-nephrotic proteinuria, and the rate of decline in GFR and the frequency of ESRF were much lower in stratum 1 than they had been instratum 2.
American Journal of EpidemiologyUnderestimation of Risk Associations Due to Regression Dilution in Long-term Follow-up of Prospective Studies
845 Citations1999Robert Clarke, M. Shipley +5 more
The analyses were based on biennial remeasurements over 30 years for participants in the Framingham Study and a 26-year resurvey for a sample of men in the Whitehall Study and show that uncorrected associations of disease risk with baseline measurements underestimate the strength of the real associations with usual levels of these risk factors during the first decade of exposure.
The LancetEffect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
668 Citations1992Salim Yusuf, Carl J. Pepine +8 more
Enalapril treatment significantly reduced myocardial infarction, unstable angina, and cardiac mortality in patients with low ejection fractions.
The LancetRenal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial
571 Citations1998Piero Ruggenenti, Annalisa Perna +4 more
In patients with chronic nephropathy and high risk of rapid progression to ESRF, ramipril reversed the tendency of GFR to decline with time and a treatment period of sufficient duration eliminated the need for dialysis.
CirculationEmerging role of angiotensin-converting enzyme inhibitors in cardiac and vascular protection.
505 Citations1994Eva Lonn, Salim Yusuf +5 more
A new and important potential role for ACE inhibitors is suggested by the recent trials in patients with low ejection fraction, which documented a significant reduction in major ischemic events such as myocardial infarction, unstable angina, and the need for coronary revascularization procedures.
DiabetologiaAngiotensin II and the endocrine pancreas: effects on islet blood flow and insulin secretion in rats
310 Citations1998Per‐Ola Carlsson, Christian Berne +1 more
It is suggested that the angiotensin-system is important in regulation of islet blood flow and points to a pivotal role of islets blood perfusion for an adequate insulin release.
Journal of HypertensionCo-expression of renin-angiotensin system genes in human adipose tissue
234 Citations1999Stefan Engeli, Kerstin Gorzelniak +4 more
The findings suggest the presence of a local renin -angiotensin system in human adipose tissue, with adipocytes being an important part of this system, and prompt speculation that this local ren in-angiotENSin system may be involved in obesity-related disorders, including hypertension and the metabolic syndrome.